GSK3B and hepatocellular carcinoma: Therefore, YANG Qing et al. [113] studied miR-192 suppression of HCC progression via GSK3β/Wnt/β-catenin signaling pathway inhibition, and developed a sodium alginate-polyethyleneimine hydrogel platform for loading miR-192.